Irish Life Investment Managers’s Impax Laboratories, Inc. IPXL Stock Holding History

Irish Life Investment Managers’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$68.3K	Buy	+3,426	New	+$60.8K	﹤0.01%	1133

Other funds holding IPXL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Irish Life Investment Managers's IPXL Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Impax Laboratories, Inc. (IPXL) in Q2 2013: 3,426 shares worth $68.3K. The stake represents ﹤0.01% of the portfolio and ranks #1133 among its holdings.

149 funds tracked by Wall St. Rank hold IPXL as of Q2 2013.

Irish Life Investment Managers held 3,426 shares of Impax Laboratories, Inc. worth $68.3K as of Q2 2013.
Impax Laboratories, Inc. was a new Irish Life Investment Managers position in Q2 2013.
Impax Laboratories, Inc. made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1133 holding.
149 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.